about us

The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries. We work with our partners to strengthen the capabilities of governments and the private sector to create and sustain high-quality health systems that can succeed without our assistance.

about us

The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries. We work with our partners to strengthen the capabilities of governments and the private sector to create and sustain high-quality health systems that can succeed without our assistance.

Our History
CHAI was founded in 2002 with a transformational goal: help save the lives of millions of people living with HIV/AIDS. Today, along with HIV, we work with partners to prevent and treat malaria, tuberculosis, hepatitis, and cancer, accelerate the rollout of lifesaving vaccines, reduce maternal, infant and child mortality, combat chronic malnutrition, and strengthen health systems. We operate in over 30 countries around the world and more than 80 countries have access to CHAI-negotiated deals on medications, diagnostics, vaccines, and other health tools.

2002

CHAI founded

CHAI is founded to help save the lives of millions of people living with HIV/AIDS in low- and-middle income countries.

CHAI is founded to help save the lives of millions of people living with HIV/AIDS in low- and-middle income countries.

2002- 2003

CHAI’s first program: HIV/AIDS

First programs begin in Africa and the Caribbean, aimed at scaling up HIV/AIDS care and treatment in entire countries. 800,000 people are treated in these countries in five years as a result of this work, up from a total of 2,000 when the work began.

First programs begin in Africa and the Caribbean, aimed at scaling up HIV/AIDS care and treatment in entire countries. 800,000 people are treated in these countries in five years as a result of this work, up from a total of 2,000 when the work began.

Alt text

2003

HIV first-line agreement

CHAI negotiates lower prices for first-line HIV drugs by over 60 percent, enabling over 60 countries to access the new prices.

CHAI negotiates lower prices for first-line HIV drugs by over 60 percent, enabling over 60 countries to access the new prices.

Alt text

2003

ART program in South Africa

CHAI begins work with South Africa to scale up treatment, laying the foundation for the largest antiretroviral therapy (ART) program in the world.

CHAI begins work with South Africa to scale up treatment, laying the foundation for the largest antiretroviral therapy (ART) program in the world.

2004

Reducing CD4 test prices

CHAI negotiates 50-90 percent price reductions for CD4 diagnostic tests for AIDS patients worldwide and enables nationwide scale-up of CD4 testing in over 40 countries.

CHAI negotiates 50-90 percent price reductions for CD4 diagnostic tests for AIDS patients worldwide and enables nationwide scale-up of CD4 testing in over 40 countries.

2004- 2005

Pediatric HIV treatment

CHAI leads global effort alongside Unitaid to scale up treatment for children with AIDS in 34 countries, from around 75,000 on treatment to over 900,000 today, lowering the price of medications from over US$600 to around US$60 per child, per year.

CHAI leads global effort alongside Unitaid to scale up treatment for children with AIDS in 34 countries, from around 75,000 on treatment to over 900,000 today, lowering the price of medications from over US$600 to around US$60 per child, per year.

2004- 2006

Engagement in China and India

CHAI assists the governments of China and India to scale up HIV/AIDS care and treatment. These efforts help stem the growth of HIV/AIDS in these countries.

CHAI assists the governments of China and India to scale up HIV/AIDS care and treatment. These efforts help stem the growth of HIV/AIDS in these countries.

2005- 2007

HIV second-line agreement

CHAI works with Unitaid to negotiate agreements to lower the price of second-line HIV/AIDS treatments by 75 percent and accelerate the roll out of these drugs to over 30 countries where patients were failing on first-line treatments.

CHAI works with Unitaid to negotiate agreements to lower the price of second-line HIV/AIDS treatments by 75 percent and accelerate the roll out of these drugs to over 30 countries where patients were failing on first-line treatments.

2005- 2008

Engagement in Southeast Asia

CHAI works with governments in Southeast Asia to scale up care and treatment programs for AIDS, including areas such as Papua New Guinea and Papua Indonesia, which have the highest AIDS rates in Asia and are among the most remote places on earth.

CHAI works with governments in Southeast Asia to scale up care and treatment programs for AIDS, including areas such as Papua New Guinea and Papua Indonesia, which have the highest AIDS rates in Asia and are among the most remote places on earth.

2007

Expansion into malaria

CHAI launches a malaria program, which grows rapidly to help government partners increase funding to combat malaria, improve access to quality diagnosis and treatment, and support evidence-based decision making to target resources and accelerate progress toward elimination.

CHAI launches a malaria program, which grows rapidly to help government partners increase funding to combat malaria, improve access to quality diagnosis and treatment, and support evidence-based decision making to target resources and accelerate progress toward elimination.

2008- 2011

Mother-to-child transmission of HIV

CHAI helps reduce mother-to-child transmission of HIV by 40 percent in high-burden areas in six countries.

CHAI helps reduce mother-to-child transmission of HIV by 40 percent in high-burden areas in six countries.

2009

Scale-up HIV care and treatment in South Africa

CHAI assists the government of South Africa with the largest scale-up of HIV care and treatment ever attempted, from 800,000 people in 2009 to approximately 3 million today. CHAI helps negotiate agreements to lower HIV and TB drug prices that save the South African government almost US$1 billion.

CHAI assists the government of South Africa with the largest scale-up of HIV care and treatment ever attempted, from 800,000 people in 2009 to approximately 3 million today. CHAI helps negotiate agreements to lower HIV and TB drug prices that save the South African government almost US$1 billion.

2010

Rapid diagnostic tests for malaria

CHAI begins to scale up access to rapid diagnostic tests for malaria in places where malaria cases are treated but diagnosis is not available. CHAI helps procure nearly 2 million low-cost tests across Kenya and Tanzania.

CHAI begins to scale up access to rapid diagnostic tests for malaria in places where malaria cases are treated but diagnosis is not available. CHAI helps procure nearly 2 million low-cost tests across Kenya and Tanzania.

2011

Expansion into vaccines

CHAI begins work to lower costs and increase access to  vaccines. Alongside the Bill & Melinda Gates Foundation, CHAI negotiates a landmark agreement to lower the price of the Rotavirus vaccine by 67 percent and the Pentavalent vaccine by 50 percent, saving the global community over US$800 million US$150 million respectively.

CHAI begins work to lower costs and increase access to  vaccines. Alongside the Bill & Melinda Gates Foundation, CHAI negotiates a landmark agreement to lower the price of the Rotavirus vaccine by 67 percent and the Pentavalent vaccine by 50 percent, saving the global community over US$800 million US$150 million respectively.

2011

MATCH study launch

CHAI, with support from the Bill & Melinda Gates Foundation, conducts the Multi-Country Analysis of Treatment Costs for HIV/AIDS (MATCH) with the governments of Ethiopia, Malawi, Rwanda, South Africa, and Zambia, using evidence to inform debate on affordability and sustainability of universal access to treatment. As a result, an additional 443,000 patients are eligible for treatment.

CHAI, with support from the Bill & Melinda Gates Foundation, conducts the Multi-Country Analysis of Treatment Costs for HIV/AIDS (MATCH) with the governments of Ethiopia, Malawi, Rwanda, South Africa, and Zambia, using evidence to inform debate on affordability and sustainability of universal access to treatment. As a result, an additional 443,000 patients are eligible for treatment.

2011

Expansion into human resources for health

CHAI helps the government of Rwanda establish a world-class health system through educating doctors, nurses, and health managers. CHAI eventually expands this work to other countries including Liberia, Malawi, and Zambia.

CHAI helps the government of Rwanda establish a world-class health system through educating doctors, nurses, and health managers. CHAI eventually expands this work to other countries including Liberia, Malawi, and Zambia.

2012

Long-acting reversible contraception

CHAI negotiates an agreement to lower the price of long-acting reversible contraceptives from US$18 to US$8.50 per implant and accelerates roll out of the products to save the lives of women.

CHAI negotiates an agreement to lower the price of long-acting reversible contraceptives from US$18 to US$8.50 per implant and accelerates roll out of the products to save the lives of women.

2013

Improving severe malaria treatment

CHAI works to lower the cost and increase the availability of injectable artesunate, a malaria medicine that can dramatically decrease malaria mortality, particularly in children.

CHAI works to lower the cost and increase the availability of injectable artesunate, a malaria medicine that can dramatically decrease malaria mortality, particularly in children.

2013

Treating childhood diarrhea

CHAI begins work to reduce mortality from diarrhea for children under five, scaling up access to lifesaving zinc/ORS treatment in India, Kenya, Nigeria, and Uganda. CHAI supports governments to lower the cost of zinc/ORS products, resulting in wholesale prices dropping by approximately 60 percent.

CHAI begins work to reduce mortality from diarrhea for children under five, scaling up access to lifesaving zinc/ORS treatment in India, Kenya, Nigeria, and Uganda. CHAI supports governments to lower the cost of zinc/ORS products, resulting in wholesale prices dropping by approximately 60 percent.

2014

Viral load diagnostics deal

CHAI negotiates a global access price for viral load diagnostics of US$9.40 per test, which will save over US$150 million over five years and dramatically improves the quality of care for HIV patients.

CHAI negotiates a global access price for viral load diagnostics of US$9.40 per test, which will save over US$150 million over five years and dramatically improves the quality of care for HIV patients.

2014

Point-of-care CD4 price reduction

CHAI negotiates a 67 percent price reduction for service and maintenance of the first point-of-care CD4 diagnostic tool, called Pima, for HIV. CHAI accelerates the market entry of a second supplier, called BD FACS Presto, which will facilitate further price reductions for point-of-care CD4 tests.

CHAI negotiates a 67 percent price reduction for service and maintenance of the first point-of-care CD4 diagnostic tool, called Pima, for HIV. CHAI accelerates the market entry of a second supplier, called BD FACS Presto, which will facilitate further price reductions for point-of-care CD4 tests.

2014

Scale up of early infant diagnostic tests

With the support of Unitaid, more than one million HIV diagnostic tests for infants are performed globally, up from 80,000 tests in 2007.

With the support of Unitaid, more than one million HIV diagnostic tests for infants are performed globally, up from 80,000 tests in 2007.

2014

Introducing new products to treat childhood diarrhea

CHAI helps introduce more than 15 new high-quality, affordable zinc and ORS products, including co-packaged products, into local markets in CHAI partner countries. The increased market competition leads to wholesale prices being reduced by 40 to 75 percent.

CHAI helps introduce more than 15 new high-quality, affordable zinc and ORS products, including co-packaged products, into local markets in CHAI partner countries. The increased market competition leads to wholesale prices being reduced by 40 to 75 percent.

2014

Ebola response in Liberia

CHAI helps lead case management and health worker training in response to the Ebola crisis in Liberia, serving as a critical link between the international emergency response and the Liberian government.

CHAI helps lead case management and health worker training in response to the Ebola crisis in Liberia, serving as a critical link between the international emergency response and the Liberian government.

2015

Expansion into new programs

CHAI introduces new programs in hepatitis, pneumonia, and cancer.

CHAI introduces new programs in hepatitis, pneumonia, and cancer.

2015- 2016

Reducing mother and infant deaths in Nigeria

CHAI introduces a comprehensive community-based approach to save mothers and newborns in Northern Nigeria through improved outreach, treatment, and training of health workers, resulting in a sustained 37 percent reduction in maternal deaths, a 43 percent reduction in newborn deaths, and a 15 percent reduction in stillbirths within 12 months.

CHAI introduces a comprehensive community-based approach to save mothers and newborns in Northern Nigeria through improved outreach, treatment, and training of health workers, resulting in a sustained 37 percent reduction in maternal deaths, a 43 percent reduction in newborn deaths, and a 15 percent reduction in stillbirths within 12 months.

2016

Lowering the cost of hepatitis C treatment

CHAI helps reduce the cost of hepatitis C treatment in seven countries by 71 to 95 percent, from US$2,618 per patient to between US$133 and US$789 per patient treated.

CHAI helps reduce the cost of hepatitis C treatment in seven countries by 71 to 95 percent, from US$2,618 per patient to between US$133 and US$789 per patient treated.

2017

Increasing access to cancer medications

CHAI announces an agreement with the American Cancer Society, Pfizer Inc., and Cipla Inc. to expand access to 16 essential cancer treatment medications, including chemotherapies, in Kenya, Tanzania, Ethiopia, Uganda, Nigeria, and Rwanda, where 44 percent of cancer cases in sub-Saharan Africa occur.

CHAI announces an agreement with the American Cancer Society, Pfizer Inc., and Cipla Inc. to expand access to 16 essential cancer treatment medications, including chemotherapies, in Kenya, Tanzania, Ethiopia, Uganda, Nigeria, and Rwanda, where 44 percent of cancer cases in sub-Saharan Africa occur.

2017

Affordable single-pill HIV regimen with DTG

CHAI and partners announce a groundbreaking agreement to accelerate the availability of the first affordable, generic, single-pill HIV treatment  containing DTG, a best-in-class HIV medication, to public sector purchasers in low- and middle-income countries at around $US75 per person, per year.

CHAI and partners announce a groundbreaking agreement to accelerate the availability of the first affordable, generic, single-pill HIV treatment  containing DTG, a best-in-class HIV medication, to public sector purchasers in low- and middle-income countries at around $US75 per person, per year.

2018

Breakthrough pricing agreement for latest diagnostic technology

CHAI and partners reach a breakthrough pricing agreement to significantly lower the cost of state-of-the art diagnostic testing for HIV, hepatitis, and cervical cancer in low-and middle-income countries at a price of US$12 per patient sample.

CHAI and partners reach a breakthrough pricing agreement to significantly lower the cost of state-of-the art diagnostic testing for HIV, hepatitis, and cervical cancer in low-and middle-income countries at a price of US$12 per patient sample.

  • CHAI founded
  • CHAI’s first program: HIV/AIDS
  • HIV first-line agreement
  • ART program in South Africa
  • Reducing CD4 test prices
  • Pediatric HIV treatment
  • Engagement in China and India
  • HIV second-line agreement
  • Engagement in Southeast Asia
  • Expansion into malaria
  • Mother-to-child transmission of HIV
  • Scale-up HIV care and treatment in South Africa
  • Rapid diagnostic tests for malaria
  • Expansion into vaccines
  • MATCH study launch
  • Expansion into human resources for health
  • Long-acting reversible contraception
  • Improving severe malaria treatment
  • Treating childhood diarrhea
  • Viral load diagnostics deal
  • Point-of-care CD4 price reduction
  • Scale up of early infant diagnostic tests
  • Introducing new products to treat childhood diarrhea
  • Ebola response in Liberia
  • Expansion into new programs
  • Reducing mother and infant deaths in Nigeria
  • Lowering the cost of hepatitis C treatment
  • Increasing access to cancer medications
  • Affordable single-pill HIV regimen with DTG
  • Breakthrough pricing agreement for latest diagnostic technology
  • 2002
  • 2003
  • 2004
  • 2005
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Senior Leadership
Dr. Iain Barton

Chief Executive Officer

Dr. Iain Barton is Chief Executive Officer of the Clinton Health Access Initiative (CHAI).

Iain is an expert in developing and implementing best practices for global health. A committed South African, he is a medical doctor with 10 years clinical practice and 20 years in healthcare business management, specializing in pharmaceutical supply and market shaping.

Iain’s most recent role before joining CHAI was as Executive Vice-President—Healthcare for Imperial Logistics, Africa’s largest supplier of medications, where he coordinated strategy, innovation, and solution design across all of the company’s healthcare businesses and drove new market expansion.

Iain was responsible for developing the concept of Regional Distribution Centers to support the scale-up of PEPFAR across the continent and of the Supply Chain Control Tower that supports the Global Fund’s Pooled Procurement Mechanism for antiretroviral medications for HIV. Other innovations developed under Iain’s leadership include Unjani Clinics, Warehouse-in-a-Box, Clinic-in-a-Box and SSiH – a mega-distributor model enhancing access to medicines across Africa.

Ira C. Magaziner

Founding Chief Executive

Ira C. Magaziner is Founding Chief Executive of the Clinton Health Access Initiative (CHAI).

In 2002, Mr. Magaziner co-founded CHAI with President Bill Clinton. From 1993 through 1998, he served as Senior Advisor to President Clinton for Policy Development at the White House. In this capacity, he supervised the development and implementation of the administration’s policy for commercialization of the Internet and worked with First Lady Hillary Rodham Clinton on the development of the President’s Health Reform Initiative. Mr. Magaziner also chaired a joint National Economic Council/National Security Council Initiative to increase US exports and served as a member of the National Domestic Policy Council.

Mr. Magaziner is one of America’s most respected corporate strategists. Prior to his White House appointment, he built two successful consulting firms and worked for the Boston Consulting Group in Boston, London, and Tokyo, helping major corporations develop their business strategies. Mr. Magaziner graduated from Brown University as valedictorian of the class of 1969, and attended Balliol College, Oxford as a Rhodes Scholar.

Alice Kang’ethe

Chief Operating Officer

Alice Kang’ethe is the Chief Operating Officer at the Clinton Health Access Initiative (CHAI). Ms. Kang’ethe joined CHAI in 2005, having previously volunteered in 2003, when she helped develop the first comprehensive HIV/AIDS care and treatment plans for the governments of South Africa and Tanzania.

Most recently Ms. Kang’ethe served as the Executive Vice President of the Vaccines, Human Resources for Health, and Family Planning programs. In this capacity she oversaw the development and execution of CHAI’s global vaccine delivery and family planning strategy to accelerate the introduction of new vaccines, enhance the performance and efficiency of vaccine cold chain systems and to accelerate the uptake of long acting reversible contraceptives, expanding access to contraception. She previously served as the Deputy Country Director of Kenya, where she was instrumental in the design and implementation of an innovative Human Resources for Health program focusing on the deployment, training, and mentorship of healthcare workers in rural districts. She also launched CHAI’s Prevention of Mother-to-Child Transmission of HIV (PMTCT) program in six countries, and managed a portfolio of key CHAI countries including Lesotho, Mozambique, Swaziland, Uganda, and Zambia in her role as a Regional Director for Southern Africa.

Prior to joining CHAI, Ms. Kang’ethe was a management consultant at KPMG East Africa, where, among other assignments, she was part of the team that was appointed as the Local Fund Agent for the Global Fund to Fight AIDS, Tuberculosis and Malaria in the Eastern African region. There she helped oversee a US$320 million grant for Kenya.

Ms. Kang’ethe holds a first class degree in Economics from the Catholic University of Eastern Africa and a Masters in Economics and Human Resource Management from the London School of Economics.

Rasha Hibri, CHAI CFO, smiles into the camera.
Rasha Hibri


Chief Financial Officer

Rasha Hibri is the Chief Financial Officer (CFO) at the Clinton Health Access Initiative, Inc (CHAI). She joined CHAI in 2020 and oversees CHAI’s global finance strategy and global financial operations including Budgets and Reporting, Business System Applications, Contracts, the International Controller’s Office (including Accounting, Payroll, and Accounts Payable), Internal Audit and Risk Management, Treasury, and Office Administration.

Prior to joining CHAI, Ms. Hibri was the CFO for India, Middle East and Africa for Allergan. In 2019, she was assigned as Acting Country Manager for India. From 2015 to 2018, Ms. Hibri was the CFO for the Middle East and North Africa region at British Telecoms Global Services. She has also worked as CFO for Eli Lilly and Company in the region and as Finance Director for Merck Sharp and Dohme (MSD), where she led growth initiatives and assessed customer needs, in addition to optimizing resource efficiency and effectiveness.

Kelly McCrystal

Executive Vice President, Women and Children's Health; Chief Strategy Officer

Kelly McCrystal is the Executive Vice President of Women and Children’s Health at CHAI, overseeing programs in maternal and newborn health, sexual and reproductive health, diarrhea and pneumonia, nutrition, and women’s cancers. She also serves as Chief Strategy Officer for CHAI and led the development of CHAI’s new five-year strategy that was approved by CHAI’s Board in 2018.

Prior to these roles, Ms. McCrystal was the head of New Initiatives at CHAI, leading the design and launch of CHAI’s maternal and newborn health program, which in its first pilot implementation in Northern Nigeria, led to a 37 percent reduction in maternal deaths and 43 percent reduction in newborn deaths in a span of 12 months. She also led the development and launch of CHAI’s nutrition and cancer programs.

Ms. McCrystal joined CHAI in 2011 as Deputy Country Director in Tanzania, where subsequently as Country Director she directed the expansion of CHAI’s programs in Tanzania to include supporting the government’s introduction of new vaccines and expanding malaria rapid testing in the private sector.

Prior to joining CHAI, Ms. McCrystal spent 17 years designing and implementing large-scale e-commerce and information systems for various companies. Ms. McCrystal also started a successful technology training company in partnership with the University of California-Irvine.

Ms. McCrystal received a Bachelor of Arts in Economics from the University of Notre Dame and a Masters of Business Administration in Finance from the Wharton School, University of Pennsylvania.

Dr. David Ripin

Executive Vice President, Infectious Diseases; Chief Science Officer

Dr. David Ripin is the Executive Vice President of Infectious Diseases, and the Chief Science Officer at the Clinton Health Access Initiative (CHAI). In these roles, he oversees CHAI’s work on increasing access to medicines and diagnostics for HIV, malaria, tuberculosis, and other disease areas through the use of sustainable market interventions. CHAI’s Access program has successfully implemented agreements with pharmaceutical companies to lower the price of key drugs and diagnostics by up to 80 percent, among other achievements. He also oversees the strategy and work of CHAI’s Malaria program.

Dr. Ripin joined CHAI in 2007. Prior to assuming his current role, he led CHAI’s Pharmaceutical Sciences Team, which conducts research and development work. These efforts focus on reducing the cost of key drugs through recommending formulation, manufacturing process, and sourcing improvements, as well as conducting the transfer of these processes to manufacturing partners.

Dr. Ripin is actively involved in setting international priorities for HIV drug optimization work, including organizing the Conference on Antiretroviral Drug Optimization in 2009. Before joining CHAI, he worked at Pfizer, Inc. for 10 years as part of the research and development group, focusing on the commercialization and manufacturing of drug candidates.

Dr. Ripin received a Bachelor of Science in Chemistry and Asian Studies from the Washington University in St. Louis and obtained his Ph.D. in Chemistry from Harvard University.

Dr. Owens Wiwa

Executive Vice President, West and Central Africa; Country Director – Nigeria

Dr. Owens Wiwa is an Executive Vice President, Regional Director of West and Central Africa and the Country Director in Nigeria for the Clinton Health Access Initiative (CHAI). He joined CHAI in 2007. Dr. Wiwa heads CHAI’s Nigeria office and plays a leadership role in health policy development and implementation at the Federal and State levels.

From 1998 to 2007, Dr. Wiwa worked with the Faculty of Medicine at the University of Toronto, designing and leading research projects that focused on infectious diseases (especially HIV), and community and mental health in Africa and Nigeria. Prior to CHAI, Dr Wiwa worked extensively as a physician in rural Nigeria and as a human and environmental rights activist with organizations such as Sierra Club and Amnesty International.

Dr. Wiwa has an MPH from Johns Hopkins University and an MB BCH from the University of Calabar.

Program and Regional Leadership
Dr. Yigeremu Abebe Asemere

Vice President and Country Director - Ethiopia

Dr. Yigeremu Abebe Asemere is a Vice President and is the Country Director in Ethiopia for the Clinton Health Access Initiative (CHAI). Dr. Yigeremu joined CHAI in 2006, and remains committed to leading the large Ethiopia country program in saving the lives of those suffering from HIV/AIDS and other preventable and treatable diseases.

Dr. Yigeremu received his undergraduate degree from the Addis Ababa University medical faculty in 1982, and began his career working in the military health services as a general practitioner for two years before receiving his postgraduate diploma in internal medicine in 1988. During his residency program, Dr. Yigeremu was the first to present on the potential threat of HIV/AIDS to Ethiopia, and since that time has dedicated his life to fighting the epidemic in his country.

Prior to joining CHAI, Dr. Yigeremu worked in the Army Health services in a variety of roles, serving as a general practitioner, an internist, a medical director for the referral hospital in Addis Ababa, and finally for five years as the Director of Health Services for the Ethiopian Army. During this time, Dr. Yigeremu organized a strong prevention and treatment program for Army staff and families; the program has been recognized among the best of its kind. He also wrote AIDS policies for the Army and worked with a broad spectrum of partners on implementation of the Army AIDS program. At the national level, he led a number of committees that wrote the national policy on AIDS, ART guidelines, and treatment guidelines and protocols.

After leaving the Army, Dr. Yigeremu organized and led the state-of-the-art fee HIV care and ART center at a major government hospital in Addis Ababa, in collaboration with a number of local and international partners. This free care program has been recognized for its comprehensive and community-based care approach that addresses patients’ basic needs and ensures adherence in an at-home environment.

Joshua Chu

Executive Vice President, Vaccines and Non-Communicable Diseases

Joshua Chu is Executive Vice President of Vaccines and Non-Communicable Diseases at the Clinton Health Access Initiative (CHAI). He is responsible for CHAI’s work to accelerate the introduction of new vaccines, improve implementation of national immunization strategies and lower the prices of essential vaccines and cold chain equipment. He also oversees CHAI’s work in cancer and will be leading the development and launch of new programs in diabetes and cardiovascular diseases.

Mr. Chu joined CHAI in 2009. Prior to assuming his current roles, he first served as Deputy Country Director in Nigeria and then as Regional Director of Southeast Asia. During his tenure in Nigeria, CHAI expanded its scope to include new programs in vaccines, family planning, essential treatments for diarrhea, and human resources for health. As Regional Director, he oversaw the development of new programs in the region which includes Cambodia, Indonesia, Laos, Myanmar, Papua New Guinea, and Vietnam.

Prior to joining CHAI, Mr. Chu held several roles including managing Singapore Airlines’ multi-billion-dollar investment portfolio of companies in Europe, Asia, and Oceania. In addition, he has held consulting and operational roles with various organizations in China, Kazakhstan, United States, and Zambia.

Mr. Chu obtained his Bachelor of Science in Economics and Bachelor of Arts in Middle Eastern and Asian studies (summa cum laude) from the Wharton School, University of Pennsylvania. He later obtained a Mphil in Development Studies (with distinction) from St Johns’ College, University of Cambridge, as a Maxis scholar.

Harkesh Dabas

Vice President and Country Director – India

Harkesh Dabas is a Vice President and is the Country Director in India. In this role, he provides leadership and strategic direction to CHAI operations and partnerships in India. Previously, Mr. Dabas led CHAI’s Access program efforts in new initiatives and organizational engagement with manufacturers of generic ARVs as well as other drug and vaccines.

Prior to joining CHAI, Mr. Dabas served in the Indian Navy for over two decades in various leadership positions, including Joint Director of Operations at the Ministry of Defence, where he was responsible for the development and execution of strategic plans and policies. He also commanded an anti-submarine warfare corvette and served as the Secretary to the Commanders’ Conference, the Navy’s highest strategic decision-making body, wherein he was involved in the development of strategy across a broad spectrum of issues.

Mr. Dabas holds post-graduate degrees in Nautical Science and Operations, a Masters in Defence and Strategic Studies, and a Masters in Business Administration from the Indian Institute of Management, Ahmedabad.

Gerald Macharia

Vice President, East and Southern Africa; Country Director - Kenya

Gerald Macharia is a Vice President, the Regional Director for East and Southern Africa, and the Country Director in Kenya for the Clinton Health Access Initiative (CHAI). He joined CHAI in 2005 as Country Director for Kenya, starting up the CHAI Kenya office before taking on the additional regional leadership role in 2010. As Regional Director, his responsibilities include overseeing operations in Kenya, Lesotho, Malawi, Mozambique, Rwanda, South Africa, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe.

Mr. Macharia began his career in the private sector in marketing management with a number of multi-national corporations. He spent three years working in global marketing with the Colgate Palmolive company before entering the financial services sector and serving as CEO of Faulu Kenya, one of East Africa’s largest microfinance institutions. During his time with Faulu Kenya, Mr. Macharia grew the organization from a small NGO program to one of the region’s best and most profitable microfinance in a period of five years. Mr. Macharia is credited with innovative work with the Vodafone Group to design and pilot the world-famous and award-winning M-Pesa money transfer system that has blazed the way for mobile money systems throughout the world; he helped pilot and refine the system towards its successful rollout in Kenya. He also helped to float Africa’s first microfinance corporate bond on the Nairobi stock exchange in 2005, raising US$7 million for the expansion of Faulu Kenya’s microfinance business.

Mr. Macharia graduated magna cum laude from Kenyatta University, and earned a postgraduate diploma in marketing from the Chartered Institute of Marketing in the UK, as well as a MBA from the Edinburgh Business School in the UK and an additional MBA from Kenya’s Moi University School of Business & Economics. He is also an alumnus of Stanford University’s Graduate School of Business Program of Strategy & Organization.

Mr. Macharia has previously served as the Vice President of the Association of Microfinance Institutions in Kenya, board member of the Africa Microfinance Network, Governing Council, member of the Kenya Institute of Management and the Marketing Society of Kenya and is a life member of the Institute of Economic Affairs in Kenya. He also serves as board member of Kenya’s government-owned Micro Enterprise Support Program Trust.

Dang Ngo

Vice President - Southeast Asia, Pacific; Country Director - Vietnam

Dang Ngo is the Vice President for Southeast Asia Pacific, overseeing operations and strategic priorities in Cambodia, Laos, Myanmar, and Vietnam, and covering initiatives including HIV, TB, malaria, hepatitis, vaccines, family planning, health system strengthening, and health information systems. Mr. Ngo is also CHAI’s Country Director in Vietnam, leading a high-performing team to significant successes including scaling up of HIV treatment coverage for children from 9 percent in 2006 to 86 percent in 2015 (one of the highest in the world), introducing improved diagnostic systems such as point-of-care and early infant diagnosis of HIV, introducing TB prevention programs that are dramatically reducing incidences, strengthening procurement and supply chain management systems to ensure drugs reach patients, and designing and implementing innovative SMS- and web-based health management information systems that are meaningfully improving patient referral systems and service delivery, among others.

Mr. Ngo joined CHAI in 2008 as a Program Coordinator in Vietnam and assumed the Deputy Country Director and Country Director roles in 2010 and 2011, respectively. He is also a member of CHAI’s Operations Leadership Team.

Prior to joining CHAI, Mr. Ngo developed a landmine risk prediction model using statistical tools that is changing the UN Mine Action Centre’s approach to reducing landmine incidences in Afghanistan. Additionally, he led the development of market-leading enterprise-level educational tools and websites to link students to universities. He is also an award-winning photographer.

Mr. Ngo earned a Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health in the Global Disease Epidemiology and Control Program.

Dr. Mphu Ramatlapeng

Executive Vice President – Implementation

Dr. Mphu Keneiloe Ramatlapeng is Executive Vice President for Implementation at the Clinton Health Access Initiative (CHAI). In this role, Dr. Ramatlapeng leads CHAI’s HIV/AIDS, TB, and Health Financing strategies and works closely with global partners and government leaders to drive transformational change in these program areas.

Prior to joining CHAI in 2012, Dr. Ramatlapeng served as Minister of Health and Social Welfare of Lesotho from 2007 to mid-2012, leading the overall clinical, technical, and financial management of the Ministry. In this role, she was a champion for some of Lesotho’s significant health achievements, including reducing the transmission of HIV from parents to their children. Under her leadership, in 2010 the Ministry introduced an innovative package to support mothers who cannot return to clinics to receive the basic services they need to stay healthy and give birth to HIV-negative children.

Dr. Ramatlapeng was born in Lesotho, studied medicine at Kharkov Medical School in Ukraine, and later obtained a Masters in Public Health from Johns Hopkins University. After completing her education she returned to Lesotho and worked in a number of roles across the public and private sectors. From 2005 to 2006, Dr. Ramatlapeng served as Country Director for the Clinton Foundation HIV/AIDS Initiative in Lesotho, bringing her extensive experience in pharmaceutical supply and management.

Dr. Ramatlapeng has held a number of Board Member positions over her career. Most recently, she was Vice Chair of the Board for the Global Fund to Fight AIDS, TB and Malaria from 2011 to 2013. She has also served as a member on boards of the Roll Back Malaria Partnership, the Stop TB Partnership, and the Foundation for Innovative New Diagnostics. Throughout her career, Dr. Ramatlapeng has also been a leading advocate for women in business; as a part of these efforts, she served as a founding Board Member of Women in Business in Lesotho.

Operations Leadership
Cathleen Creedon

Director of Development

Cathleen Creedon is Director of Development for the Clinton Health Access Initiative (CHAI), where she is responsible for working with CHAI’s CEO and senior leadership to secure sources of entrepreneurial funding and guidance that will enable CHAI to enter new arenas and expand upon existing opportunities that can have tremendous impact upon the future of those CHAI serves.  Since CHAI’s inception, individual and institutional supporters have played a key role in enabling CHAI’s efforts to generate large-scale impact and transform global public health.

Ms. Creedon joined CHAI in 2011. Prior to her position with CHAI, she worked with Cape Cod Healthcare in Massachusetts on the successful completion of a campaign to create a new patient wing, a cardiac center and expanded emergency services; created the first-ever major and planned giving program for the International Fund for Animal Welfare to work on issues such as the illegal trade in ivory and exploitation of marine mammals; headed fundraising in the Northeast Region for CARE, the international relief and development agency; helped expand high-level giving for The Trustees of Reservations to preserve open space for public enjoyment; and raised funds to create a science center for Buckingham, Browne and Nichols School in Cambridge, Mass.

Ms. Creedon received a Bachelor of Arts degree in English Literature from Wellesley College.

Katherine Pela DeMarco

Director of Global Operations

Katherine Pela DeMarco is Director of Global Operations at the Clinton Health Access Initiative (CHAI). She joined CHAI as a volunteer in 2008 helping the Liberia Ministry of Health draft a Global Fund HIV grant. She later joined the team full-time as the HIV Program Manager supporting grant execution to scale HIV care and treatment across the country and build ministry of health management capacity. As the Liberia country office expanded into areas of maternal and neonatal health, human resources for health, labs and supply chain, Ms. DeMarco moved into the role of Deputy Country Director. After her time in Liberia, she joined the Institutional Donor Relations team. In that role she has supported various global and country teams with their fundraising and donor compliance needs along with coordinating capacity assessments from our donors.

Prior to joining CHAI, Ms. DeMarco worked for the American Red Cross focusing on hurricane disaster preparedness and response. She then served as a Peace Corps volunteer in the same focus area in the Caribbean. She then worked for a variety of NGOs concentrating on economic development projects in Africa and the Caribbean.

Ms. DeMarco holds a Bachelor of Arts and Master’s in Public Health from Tulane University.

Regan Lachapelle

Director of Communications

Regan Lachapelle is Director of Communications at the Clinton Health Access Initiative (CHAI). She joined CHAI in 2016 and is responsible for leading communications strategy and operations and is spokesperson for the organization.

Prior to joining CHAI, Ms. Lachapelle was Senior Communications Associate at the Center on Budget and Policy Priorities (CBPP), a Washington, DC-based nonprofit. She also served as Press Director at the Millennium Challenge Corporation (MCC) and was Deputy Communications Director to former U.S. Senate Majority Leader Harry Reid (D-NV). In that role she helped manage the day-to-day operations of the national communications office, developed messaging and strategy and was a spokesperson for the Senator and the Democratic Caucus. Ms. Lachapelle also served as Deputy Press Secretary to U.S. Senator Jack Reed (D-RI).

Ms. Lachapelle received a Bachelor of Arts in Political Science and French from Albion College in Michigan.

Joseph Levy

Senior Director of Human Resources and Chief Human Resources Officer

Joseph Levy is the Senior Director of Human Resources and Chief HR Officer at the Clinton Health Access Initiative (CHAI). He leads the Global HR team and organization-wide HR strategy and services, supporting more than 1,300 staff in more than 35 countries, to ensure that CHAI’s staff remain its greatest asset.

Before CHAI, Mr. Levy worked as a strategic consultant to major universities and hospitals pursuing global health programs, conducting organizational assessments and providing advice and recommendations on global operations, global safety, human resources, and risk management. In 16 years at Harvard University, he held a variety of roles, first as a traditional HR business partner, and then as a thought leader on global issues. Beginning in 2010, he led a university-wide assessment of travel safety practices, resulting in more comprehensive support for students, faculty, and staff. He then founded Global Support Services, Harvard’s global center of excellence, which grew to encompass an internal consulting unit, a 24/7 safety and emergency response team, and a back-office service provider for country offices. Through work with stakeholders across the university, he developed a customer-focused service model that continues to support hundreds of programs and thousands of travelers across Harvard’s 12 schools.

He graduated from Harvard with a degree in folklore and mythology. He is also a certified Global Professional in Human Resources (GPHR).

Joan Muasa

Senior Director of Institutional Relations and Program Review

Joan Muasa is a Senior Director, responsible for strategic planning, institutional donor management, and coordination of the Clinton Health Access Initiative’s (CHAI) Program Leadership Team and program reviews. Prior to assuming her current position, Ms. Muasa served as Director of Budgeting and Reporting. During her tenure in that role, she collaborated to form new finance and accounting departments; established financial policies, tools, processes, and practices that aided the development of CHAI’s revenue recognition and allocation, multi-year and annual financial planning, and management reporting processes; improved donor compliance; and restructured the program cost allocation process.

Prior to joining CHAI, Ms. Muasa spent 12 years at Oxfam (Oxfam UK and Oxfam America, Inc.) as a senior finance and operations director. While at Oxfam UK, she was instrumental in the design and implementation of the international division’s five-year strategic planning, annual programming, and business planning processes in 80 countries and also led the streamlining of restricted fund management and the decentralization of the international division’s 80 percent donor management (about 400 grants) from HQ into regional and country offices. She also served in a variety of other capacities at Oxfam. Her accomplishments include work in financial and operational management, organizational strategic and annual planning, risk management, process and systems improvements, change management, partner relations, and program evaluations.

Ms. Muasa has managed programs and lived in East and West Africa, Southeast Asia, the UK and the US. She currently serves on the boards of two charitable organizations that focus on secondary school education and vocational training of marginalized children and youth in East Africa. Ms. Muasa holds a Bachelor of Arts degree in Economics from the University of Nairobi, Kenya, and is a Kenyan certified accountant. She is also an alumna of Said Business School, Oxford, UK on Strategy, Risk Management, and Organizational Change.

Board of Directors
Dr. Tachi Yamada

Chair of the Board

Raymond G. Chambers

Board Member and Chair of the Executive Committee

Chelsea Clinton

Board Member

President William J. Clinton

Board Member, Chairman Emeritus and Co-Founder

Aliko Dangote

Board Member

Dr. Mark Dybul

Board Member

Dr. Paul Farmer

Board Member

Mala Gaonkar

Board Member

Bruce Lindsey

Board Member

Joy Phumaphi

Board Member

Robert W. Selander

Board Member and Chair of the Finance Committee

Alan D. Schwartz

Board Member and Chair of the Human Resources Committee

Ann Veneman

Board Member

Dr. Iain Barton

Board Member (Ex-Officio), Chief Executive Officer

Richard Zall

Board Secretary and Legal Counsel

Timothy A.A. Stiles

Chair of the Finance Committee’s Audit Subcommittee

Senior Leadership

Dr. Iain Barton

Chief Executive Officer

Dr. Iain Barton is Chief Executive Officer of the Clinton Health Access Initiative (CHAI).

Iain is an expert in developing and implementing best practices for global health. A committed South African, he is a medical doctor with 10 years clinical practice and 20 years in healthcare business management, specializing in pharmaceutical supply and market shaping.

Iain’s most recent role before joining CHAI was as Executive Vice-President—Healthcare for Imperial Logistics, Africa’s largest supplier of medications, where he coordinated strategy, innovation, and solution design across all of the company’s healthcare businesses and drove new market expansion.

Iain was responsible for developing the concept of Regional Distribution Centers to support the scale-up of PEPFAR across the continent and of the Supply Chain Control Tower that supports the Global Fund’s Pooled Procurement Mechanism for antiretroviral medications for HIV. Other innovations developed under Iain’s leadership include Unjani Clinics, Warehouse-in-a-Box, Clinic-in-a-Box and SSiH – a mega-distributor model enhancing access to medicines across Africa.

Ira C. Magaziner

Founding Chief Executive

Ira C. Magaziner is Founding Chief Executive of the Clinton Health Access Initiative (CHAI).

In 2002, Mr. Magaziner co-founded CHAI with President Bill Clinton. From 1993 through 1998, he served as Senior Advisor to President Clinton for Policy Development at the White House. In this capacity, he supervised the development and implementation of the administration’s policy for commercialization of the Internet and worked with First Lady Hillary Rodham Clinton on the development of the President’s Health Reform Initiative. Mr. Magaziner also chaired a joint National Economic Council/National Security Council Initiative to increase US exports and served as a member of the National Domestic Policy Council.

Mr. Magaziner is one of America’s most respected corporate strategists. Prior to his White House appointment, he built two successful consulting firms and worked for the Boston Consulting Group in Boston, London, and Tokyo, helping major corporations develop their business strategies. Mr. Magaziner graduated from Brown University as valedictorian of the class of 1969, and attended Balliol College, Oxford as a Rhodes Scholar.

Alice Kang’ethe

Chief Operating Officer

Alice Kang’ethe is the Chief Operating Officer at the Clinton Health Access Initiative (CHAI). Ms. Kang’ethe joined CHAI in 2005, having previously volunteered in 2003, when she helped develop the first comprehensive HIV/AIDS care and treatment plans for the governments of South Africa and Tanzania.

Most recently Ms. Kang’ethe served as the Executive Vice President of the Vaccines, Human Resources for Health, and Family Planning programs. In this capacity she oversaw the development and execution of CHAI’s global vaccine delivery and family planning strategy to accelerate the introduction of new vaccines, enhance the performance and efficiency of vaccine cold chain systems and to accelerate the uptake of long acting reversible contraceptives, expanding access to contraception. She previously served as the Deputy Country Director of Kenya, where she was instrumental in the design and implementation of an innovative Human Resources for Health program focusing on the deployment, training, and mentorship of healthcare workers in rural districts. She also launched CHAI’s Prevention of Mother-to-Child Transmission of HIV (PMTCT) program in six countries, and managed a portfolio of key CHAI countries including Lesotho, Mozambique, Swaziland, Uganda, and Zambia in her role as a Regional Director for Southern Africa.

Prior to joining CHAI, Ms. Kang’ethe was a management consultant at KPMG East Africa, where, among other assignments, she was part of the team that was appointed as the Local Fund Agent for the Global Fund to Fight AIDS, Tuberculosis and Malaria in the Eastern African region. There she helped oversee a US$320 million grant for Kenya.

Ms. Kang’ethe holds a first class degree in Economics from the Catholic University of Eastern Africa and a Masters in Economics and Human Resource Management from the London School of Economics.

Rasha Hibri, CHAI CFO, smiles into the camera.

Rasha Hibri


Chief Financial Officer

Rasha Hibri is the Chief Financial Officer (CFO) at the Clinton Health Access Initiative, Inc (CHAI). She joined CHAI in 2020 and oversees CHAI’s global finance strategy and global financial operations including Budgets and Reporting, Business System Applications, Contracts, the International Controller’s Office (including Accounting, Payroll, and Accounts Payable), Internal Audit and Risk Management, Treasury, and Office Administration.

Prior to joining CHAI, Ms. Hibri was the CFO for India, Middle East and Africa for Allergan. In 2019, she was assigned as Acting Country Manager for India. From 2015 to 2018, Ms. Hibri was the CFO for the Middle East and North Africa region at British Telecoms Global Services. She has also worked as CFO for Eli Lilly and Company in the region and as Finance Director for Merck Sharp and Dohme (MSD), where she led growth initiatives and assessed customer needs, in addition to optimizing resource efficiency and effectiveness.

Kelly McCrystal

Executive Vice President, Women and Children's Health; Chief Strategy Officer

Kelly McCrystal is the Executive Vice President of Women and Children’s Health at CHAI, overseeing programs in maternal and newborn health, sexual and reproductive health, diarrhea and pneumonia, nutrition, and women’s cancers. She also serves as Chief Strategy Officer for CHAI and led the development of CHAI’s new five-year strategy that was approved by CHAI’s Board in 2018.

Prior to these roles, Ms. McCrystal was the head of New Initiatives at CHAI, leading the design and launch of CHAI’s maternal and newborn health program, which in its first pilot implementation in Northern Nigeria, led to a 37 percent reduction in maternal deaths and 43 percent reduction in newborn deaths in a span of 12 months. She also led the development and launch of CHAI’s nutrition and cancer programs.

Ms. McCrystal joined CHAI in 2011 as Deputy Country Director in Tanzania, where subsequently as Country Director she directed the expansion of CHAI’s programs in Tanzania to include supporting the government’s introduction of new vaccines and expanding malaria rapid testing in the private sector.

Prior to joining CHAI, Ms. McCrystal spent 17 years designing and implementing large-scale e-commerce and information systems for various companies. Ms. McCrystal also started a successful technology training company in partnership with the University of California-Irvine.

Ms. McCrystal received a Bachelor of Arts in Economics from the University of Notre Dame and a Masters of Business Administration in Finance from the Wharton School, University of Pennsylvania.

Dr. David Ripin

Executive Vice President, Infectious Diseases; Chief Science Officer

Dr. David Ripin is the Executive Vice President of Infectious Diseases, and the Chief Science Officer at the Clinton Health Access Initiative (CHAI). In these roles, he oversees CHAI’s work on increasing access to medicines and diagnostics for HIV, malaria, tuberculosis, and other disease areas through the use of sustainable market interventions. CHAI’s Access program has successfully implemented agreements with pharmaceutical companies to lower the price of key drugs and diagnostics by up to 80 percent, among other achievements. He also oversees the strategy and work of CHAI’s Malaria program.

Dr. Ripin joined CHAI in 2007. Prior to assuming his current role, he led CHAI’s Pharmaceutical Sciences Team, which conducts research and development work. These efforts focus on reducing the cost of key drugs through recommending formulation, manufacturing process, and sourcing improvements, as well as conducting the transfer of these processes to manufacturing partners.

Dr. Ripin is actively involved in setting international priorities for HIV drug optimization work, including organizing the Conference on Antiretroviral Drug Optimization in 2009. Before joining CHAI, he worked at Pfizer, Inc. for 10 years as part of the research and development group, focusing on the commercialization and manufacturing of drug candidates.

Dr. Ripin received a Bachelor of Science in Chemistry and Asian Studies from the Washington University in St. Louis and obtained his Ph.D. in Chemistry from Harvard University.

Dr. Owens Wiwa

Executive Vice President, West and Central Africa; Country Director – Nigeria

Dr. Owens Wiwa is an Executive Vice President, Regional Director of West and Central Africa and the Country Director in Nigeria for the Clinton Health Access Initiative (CHAI). He joined CHAI in 2007. Dr. Wiwa heads CHAI’s Nigeria office and plays a leadership role in health policy development and implementation at the Federal and State levels.

From 1998 to 2007, Dr. Wiwa worked with the Faculty of Medicine at the University of Toronto, designing and leading research projects that focused on infectious diseases (especially HIV), and community and mental health in Africa and Nigeria. Prior to CHAI, Dr Wiwa worked extensively as a physician in rural Nigeria and as a human and environmental rights activist with organizations such as Sierra Club and Amnesty International.

Dr. Wiwa has an MPH from Johns Hopkins University and an MB BCH from the University of Calabar.

Program and Regional Leadership

Dr. Yigeremu Abebe Asemere

Vice President and Country Director - Ethiopia

Dr. Yigeremu Abebe Asemere is a Vice President and is the Country Director in Ethiopia for the Clinton Health Access Initiative (CHAI). Dr. Yigeremu joined CHAI in 2006, and remains committed to leading the large Ethiopia country program in saving the lives of those suffering from HIV/AIDS and other preventable and treatable diseases.

Dr. Yigeremu received his undergraduate degree from the Addis Ababa University medical faculty in 1982, and began his career working in the military health services as a general practitioner for two years before receiving his postgraduate diploma in internal medicine in 1988. During his residency program, Dr. Yigeremu was the first to present on the potential threat of HIV/AIDS to Ethiopia, and since that time has dedicated his life to fighting the epidemic in his country.

Prior to joining CHAI, Dr. Yigeremu worked in the Army Health services in a variety of roles, serving as a general practitioner, an internist, a medical director for the referral hospital in Addis Ababa, and finally for five years as the Director of Health Services for the Ethiopian Army. During this time, Dr. Yigeremu organized a strong prevention and treatment program for Army staff and families; the program has been recognized among the best of its kind. He also wrote AIDS policies for the Army and worked with a broad spectrum of partners on implementation of the Army AIDS program. At the national level, he led a number of committees that wrote the national policy on AIDS, ART guidelines, and treatment guidelines and protocols.

After leaving the Army, Dr. Yigeremu organized and led the state-of-the-art fee HIV care and ART center at a major government hospital in Addis Ababa, in collaboration with a number of local and international partners. This free care program has been recognized for its comprehensive and community-based care approach that addresses patients’ basic needs and ensures adherence in an at-home environment.

Joshua Chu

Executive Vice President, Vaccines and Non-Communicable Diseases

Joshua Chu is Executive Vice President of Vaccines and Non-Communicable Diseases at the Clinton Health Access Initiative (CHAI). He is responsible for CHAI’s work to accelerate the introduction of new vaccines, improve implementation of national immunization strategies and lower the prices of essential vaccines and cold chain equipment. He also oversees CHAI’s work in cancer and will be leading the development and launch of new programs in diabetes and cardiovascular diseases.

Mr. Chu joined CHAI in 2009. Prior to assuming his current roles, he first served as Deputy Country Director in Nigeria and then as Regional Director of Southeast Asia. During his tenure in Nigeria, CHAI expanded its scope to include new programs in vaccines, family planning, essential treatments for diarrhea, and human resources for health. As Regional Director, he oversaw the development of new programs in the region which includes Cambodia, Indonesia, Laos, Myanmar, Papua New Guinea, and Vietnam.

Prior to joining CHAI, Mr. Chu held several roles including managing Singapore Airlines’ multi-billion-dollar investment portfolio of companies in Europe, Asia, and Oceania. In addition, he has held consulting and operational roles with various organizations in China, Kazakhstan, United States, and Zambia.

Mr. Chu obtained his Bachelor of Science in Economics and Bachelor of Arts in Middle Eastern and Asian studies (summa cum laude) from the Wharton School, University of Pennsylvania. He later obtained a Mphil in Development Studies (with distinction) from St Johns’ College, University of Cambridge, as a Maxis scholar.

Harkesh Dabas

Vice President and Country Director – India

Harkesh Dabas is a Vice President and is the Country Director in India. In this role, he provides leadership and strategic direction to CHAI operations and partnerships in India. Previously, Mr. Dabas led CHAI’s Access program efforts in new initiatives and organizational engagement with manufacturers of generic ARVs as well as other drug and vaccines.

Prior to joining CHAI, Mr. Dabas served in the Indian Navy for over two decades in various leadership positions, including Joint Director of Operations at the Ministry of Defence, where he was responsible for the development and execution of strategic plans and policies. He also commanded an anti-submarine warfare corvette and served as the Secretary to the Commanders’ Conference, the Navy’s highest strategic decision-making body, wherein he was involved in the development of strategy across a broad spectrum of issues.

Mr. Dabas holds post-graduate degrees in Nautical Science and Operations, a Masters in Defence and Strategic Studies, and a Masters in Business Administration from the Indian Institute of Management, Ahmedabad.

Gerald Macharia

Vice President, East and Southern Africa; Country Director - Kenya

Gerald Macharia is a Vice President, the Regional Director for East and Southern Africa, and the Country Director in Kenya for the Clinton Health Access Initiative (CHAI). He joined CHAI in 2005 as Country Director for Kenya, starting up the CHAI Kenya office before taking on the additional regional leadership role in 2010. As Regional Director, his responsibilities include overseeing operations in Kenya, Lesotho, Malawi, Mozambique, Rwanda, South Africa, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe.

Mr. Macharia began his career in the private sector in marketing management with a number of multi-national corporations. He spent three years working in global marketing with the Colgate Palmolive company before entering the financial services sector and serving as CEO of Faulu Kenya, one of East Africa’s largest microfinance institutions. During his time with Faulu Kenya, Mr. Macharia grew the organization from a small NGO program to one of the region’s best and most profitable microfinance in a period of five years. Mr. Macharia is credited with innovative work with the Vodafone Group to design and pilot the world-famous and award-winning M-Pesa money transfer system that has blazed the way for mobile money systems throughout the world; he helped pilot and refine the system towards its successful rollout in Kenya. He also helped to float Africa’s first microfinance corporate bond on the Nairobi stock exchange in 2005, raising US$7 million for the expansion of Faulu Kenya’s microfinance business.

Mr. Macharia graduated magna cum laude from Kenyatta University, and earned a postgraduate diploma in marketing from the Chartered Institute of Marketing in the UK, as well as a MBA from the Edinburgh Business School in the UK and an additional MBA from Kenya’s Moi University School of Business & Economics. He is also an alumnus of Stanford University’s Graduate School of Business Program of Strategy & Organization.

Mr. Macharia has previously served as the Vice President of the Association of Microfinance Institutions in Kenya, board member of the Africa Microfinance Network, Governing Council, member of the Kenya Institute of Management and the Marketing Society of Kenya and is a life member of the Institute of Economic Affairs in Kenya. He also serves as board member of Kenya’s government-owned Micro Enterprise Support Program Trust.

Dang Ngo

Vice President - Southeast Asia, Pacific; Country Director - Vietnam

Dang Ngo is the Vice President for Southeast Asia Pacific, overseeing operations and strategic priorities in Cambodia, Laos, Myanmar, and Vietnam, and covering initiatives including HIV, TB, malaria, hepatitis, vaccines, family planning, health system strengthening, and health information systems. Mr. Ngo is also CHAI’s Country Director in Vietnam, leading a high-performing team to significant successes including scaling up of HIV treatment coverage for children from 9 percent in 2006 to 86 percent in 2015 (one of the highest in the world), introducing improved diagnostic systems such as point-of-care and early infant diagnosis of HIV, introducing TB prevention programs that are dramatically reducing incidences, strengthening procurement and supply chain management systems to ensure drugs reach patients, and designing and implementing innovative SMS- and web-based health management information systems that are meaningfully improving patient referral systems and service delivery, among others.

Mr. Ngo joined CHAI in 2008 as a Program Coordinator in Vietnam and assumed the Deputy Country Director and Country Director roles in 2010 and 2011, respectively. He is also a member of CHAI’s Operations Leadership Team.

Prior to joining CHAI, Mr. Ngo developed a landmine risk prediction model using statistical tools that is changing the UN Mine Action Centre’s approach to reducing landmine incidences in Afghanistan. Additionally, he led the development of market-leading enterprise-level educational tools and websites to link students to universities. He is also an award-winning photographer.

Mr. Ngo earned a Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health in the Global Disease Epidemiology and Control Program.

Dr. Mphu Ramatlapeng

Executive Vice President – Implementation

Dr. Mphu Keneiloe Ramatlapeng is Executive Vice President for Implementation at the Clinton Health Access Initiative (CHAI). In this role, Dr. Ramatlapeng leads CHAI’s HIV/AIDS, TB, and Health Financing strategies and works closely with global partners and government leaders to drive transformational change in these program areas.

Prior to joining CHAI in 2012, Dr. Ramatlapeng served as Minister of Health and Social Welfare of Lesotho from 2007 to mid-2012, leading the overall clinical, technical, and financial management of the Ministry. In this role, she was a champion for some of Lesotho’s significant health achievements, including reducing the transmission of HIV from parents to their children. Under her leadership, in 2010 the Ministry introduced an innovative package to support mothers who cannot return to clinics to receive the basic services they need to stay healthy and give birth to HIV-negative children.

Dr. Ramatlapeng was born in Lesotho, studied medicine at Kharkov Medical School in Ukraine, and later obtained a Masters in Public Health from Johns Hopkins University. After completing her education she returned to Lesotho and worked in a number of roles across the public and private sectors. From 2005 to 2006, Dr. Ramatlapeng served as Country Director for the Clinton Foundation HIV/AIDS Initiative in Lesotho, bringing her extensive experience in pharmaceutical supply and management.

Dr. Ramatlapeng has held a number of Board Member positions over her career. Most recently, she was Vice Chair of the Board for the Global Fund to Fight AIDS, TB and Malaria from 2011 to 2013. She has also served as a member on boards of the Roll Back Malaria Partnership, the Stop TB Partnership, and the Foundation for Innovative New Diagnostics. Throughout her career, Dr. Ramatlapeng has also been a leading advocate for women in business; as a part of these efforts, she served as a founding Board Member of Women in Business in Lesotho.

Operations Leadership

Cathleen Creedon

Director of Development

Cathleen Creedon is Director of Development for the Clinton Health Access Initiative (CHAI), where she is responsible for working with CHAI’s CEO and senior leadership to secure sources of entrepreneurial funding and guidance that will enable CHAI to enter new arenas and expand upon existing opportunities that can have tremendous impact upon the future of those CHAI serves.  Since CHAI’s inception, individual and institutional supporters have played a key role in enabling CHAI’s efforts to generate large-scale impact and transform global public health.

Ms. Creedon joined CHAI in 2011. Prior to her position with CHAI, she worked with Cape Cod Healthcare in Massachusetts on the successful completion of a campaign to create a new patient wing, a cardiac center and expanded emergency services; created the first-ever major and planned giving program for the International Fund for Animal Welfare to work on issues such as the illegal trade in ivory and exploitation of marine mammals; headed fundraising in the Northeast Region for CARE, the international relief and development agency; helped expand high-level giving for The Trustees of Reservations to preserve open space for public enjoyment; and raised funds to create a science center for Buckingham, Browne and Nichols School in Cambridge, Mass.

Ms. Creedon received a Bachelor of Arts degree in English Literature from Wellesley College.

Katherine Pela DeMarco

Director of Global Operations

Katherine Pela DeMarco is Director of Global Operations at the Clinton Health Access Initiative (CHAI). She joined CHAI as a volunteer in 2008 helping the Liberia Ministry of Health draft a Global Fund HIV grant. She later joined the team full-time as the HIV Program Manager supporting grant execution to scale HIV care and treatment across the country and build ministry of health management capacity. As the Liberia country office expanded into areas of maternal and neonatal health, human resources for health, labs and supply chain, Ms. DeMarco moved into the role of Deputy Country Director. After her time in Liberia, she joined the Institutional Donor Relations team. In that role she has supported various global and country teams with their fundraising and donor compliance needs along with coordinating capacity assessments from our donors.

Prior to joining CHAI, Ms. DeMarco worked for the American Red Cross focusing on hurricane disaster preparedness and response. She then served as a Peace Corps volunteer in the same focus area in the Caribbean. She then worked for a variety of NGOs concentrating on economic development projects in Africa and the Caribbean.

Ms. DeMarco holds a Bachelor of Arts and Master’s in Public Health from Tulane University.

Regan Lachapelle

Director of Communications

Regan Lachapelle is Director of Communications at the Clinton Health Access Initiative (CHAI). She joined CHAI in 2016 and is responsible for leading communications strategy and operations and is spokesperson for the organization.

Prior to joining CHAI, Ms. Lachapelle was Senior Communications Associate at the Center on Budget and Policy Priorities (CBPP), a Washington, DC-based nonprofit. She also served as Press Director at the Millennium Challenge Corporation (MCC) and was Deputy Communications Director to former U.S. Senate Majority Leader Harry Reid (D-NV). In that role she helped manage the day-to-day operations of the national communications office, developed messaging and strategy and was a spokesperson for the Senator and the Democratic Caucus. Ms. Lachapelle also served as Deputy Press Secretary to U.S. Senator Jack Reed (D-RI).

Ms. Lachapelle received a Bachelor of Arts in Political Science and French from Albion College in Michigan.

Joseph Levy

Senior Director of Human Resources and Chief Human Resources Officer

Joseph Levy is the Senior Director of Human Resources and Chief HR Officer at the Clinton Health Access Initiative (CHAI). He leads the Global HR team and organization-wide HR strategy and services, supporting more than 1,300 staff in more than 35 countries, to ensure that CHAI’s staff remain its greatest asset.

Before CHAI, Mr. Levy worked as a strategic consultant to major universities and hospitals pursuing global health programs, conducting organizational assessments and providing advice and recommendations on global operations, global safety, human resources, and risk management. In 16 years at Harvard University, he held a variety of roles, first as a traditional HR business partner, and then as a thought leader on global issues. Beginning in 2010, he led a university-wide assessment of travel safety practices, resulting in more comprehensive support for students, faculty, and staff. He then founded Global Support Services, Harvard’s global center of excellence, which grew to encompass an internal consulting unit, a 24/7 safety and emergency response team, and a back-office service provider for country offices. Through work with stakeholders across the university, he developed a customer-focused service model that continues to support hundreds of programs and thousands of travelers across Harvard’s 12 schools.

He graduated from Harvard with a degree in folklore and mythology. He is also a certified Global Professional in Human Resources (GPHR).

Joan Muasa

Senior Director of Institutional Relations and Program Review

Joan Muasa is a Senior Director, responsible for strategic planning, institutional donor management, and coordination of the Clinton Health Access Initiative’s (CHAI) Program Leadership Team and program reviews. Prior to assuming her current position, Ms. Muasa served as Director of Budgeting and Reporting. During her tenure in that role, she collaborated to form new finance and accounting departments; established financial policies, tools, processes, and practices that aided the development of CHAI’s revenue recognition and allocation, multi-year and annual financial planning, and management reporting processes; improved donor compliance; and restructured the program cost allocation process.

Prior to joining CHAI, Ms. Muasa spent 12 years at Oxfam (Oxfam UK and Oxfam America, Inc.) as a senior finance and operations director. While at Oxfam UK, she was instrumental in the design and implementation of the international division’s five-year strategic planning, annual programming, and business planning processes in 80 countries and also led the streamlining of restricted fund management and the decentralization of the international division’s 80 percent donor management (about 400 grants) from HQ into regional and country offices. She also served in a variety of other capacities at Oxfam. Her accomplishments include work in financial and operational management, organizational strategic and annual planning, risk management, process and systems improvements, change management, partner relations, and program evaluations.

Ms. Muasa has managed programs and lived in East and West Africa, Southeast Asia, the UK and the US. She currently serves on the boards of two charitable organizations that focus on secondary school education and vocational training of marginalized children and youth in East Africa. Ms. Muasa holds a Bachelor of Arts degree in Economics from the University of Nairobi, Kenya, and is a Kenyan certified accountant. She is also an alumna of Said Business School, Oxford, UK on Strategy, Risk Management, and Organizational Change.

Board of Directors

Dr. Tachi Yamada

Chair of the Board

Raymond G. Chambers

Board Member and Chair of the Executive Committee

Chelsea Clinton

Board Member

President William J. Clinton

Board Member, Chairman Emeritus and Co-Founder

Aliko Dangote

Board Member

Professor Dame Sally Davies

Board Member

Dr. Mark Dybul

Board Member

Dr. Paul Farmer

Board Member

Mala Gaonkar

Board Member

Bruce Lindsey

Board Member

Joy Phumaphi

Board Member

Robert W. Selander

Board Member and Chair of the Finance Committee

Alan D. Schwartz

Board Member and Chair of the Human Resources Committee

Ann Veneman

Board Member

Dr. Iain Barton

Board Member (Ex-Officio), Chief Executive Officer

Richard Zall

Board Secretary and Legal Counsel

Timothy A.A. Stiles

Chair of the Finance Committee’s Audit Subcommittee

Join Our Team

CHAI is looking for dynamic and self-motivated individuals who are committed to strengthening health systems around the world and expanding access to care and treatment of HIV/AIDS, malaria, and other illnesses. View All CHAI Positions

Join Our Team

CHAI is looking for dynamic and self-motivated individuals who are committed to strengthening health systems around the world and expanding access to care and treatment of HIV/AIDS, malaria, and other illnesses. View All CHAI Positions